Skip to main content
. Author manuscript; available in PMC: 2009 Sep 1.
Published in final edited form as: Neuropharmacology. 2008 Mar 4;55(3):363–389. doi: 10.1016/j.neuropharm.2007.12.007

Figure 5.

Figure 5

Efficacy analysis in ALIAS (Albumin in Acute Stroke) Pilot Trial, comparing modified Rankin scale (mRS) at 3 months in tPA subjects who received lower-dose versus higher-dose albumin treatment. [ Reproduced with permission from (Palesch et al., 2006)].